Literature DB >> 23946529

Chronic empyema: importance of preventing complications in the management of pleural effusions.

Viktor Molander1, Maria Diakopoulou, Lotta Orre, Giovanni Ferrara.   

Abstract

We report a case of chronic empyema in a 63-year-old man with a history of asbestos exposure and alcohol overconsumption. In 2009, he presented with dyspnoea, exudative pleurisy on the right side with no symptoms of infection or malignancy. In 2013, the patient presented with increased dyspnoea and a massive chronic empyema had evolved. Culture of the pleural fluid was positive for Escherichia coli and anaerobic bacteria, and he was treated with antibiotics, chest drainage as well as surgical evacuation. After surgery, as the lung failed to expand, growth of opportunistic bacteria and rising C reactive protein obliged long-time treatment with broad-spectrum antibiotics as well as chest drainage with daily saline flushes. The patient still suffers from fatigue, poor nutritional status and anaemia, and further treatment with chest drainage and antibiotics is planned. Advanced chronic empyema is a difficult condition with poor response to treatment, and diagnostic delay is the main cause of complications.

Entities:  

Mesh:

Year:  2013        PMID: 23946529      PMCID: PMC3762540          DOI: 10.1136/bcr-2013-200454

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  Impact of alcohol abuse in the etiology and severity of community-acquired pneumonia.

Authors:  Andrés de Roux; Manuela Cavalcanti; Maria Angeles Marcos; Elisa Garcia; Santiago Ewig; José Mensa; Antoni Torres
Journal:  Chest       Date:  2006-05       Impact factor: 9.410

2.  Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity.

Authors:  M Ruiz; S Ewig; M A Marcos; J A Martinez; F Arancibia; J Mensa; A Torres
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

Review 3.  Straightening out chest tubes: what size, what type, and when.

Authors:  Kamran Mahmood; Momen M Wahidi
Journal:  Clin Chest Med       Date:  2013-01-17       Impact factor: 2.878

Review 4.  Treatment of complicated pleural effusions in 2013.

Authors:  Rahul Bhatnagar; Nick A Maskell
Journal:  Clin Chest Med       Date:  2013-01-17       Impact factor: 2.878

Review 5.  Intrapleural fibrinolytic therapy for treatment of adult parapneumonic effusions and empyemas: a systematic review and meta-analysis.

Authors:  Surinder Janda; John Swiston
Journal:  Chest       Date:  2012-08       Impact factor: 9.410

6.  Empyema: an increasing concern in Canada.

Authors:  Christian Finley; Joanne Clifton; J Mark Fitzgerald; John Yee
Journal:  Can Respir J       Date:  2008-03       Impact factor: 2.409

Review 7.  Pleurectomy decortication in the treatment of the "trapped lung" in benign and malignant pleural effusions.

Authors:  Sridhar Rathinam; David A Waller
Journal:  Thorac Surg Clin       Date:  2013-02       Impact factor: 1.750

Review 8.  The increasing incidence of empyema.

Authors:  Joaquín Burgos; Vicenç Falcó; Albert Pahissa
Journal:  Curr Opin Pulm Med       Date:  2013-07       Impact factor: 3.155

9.  Ability of procalcitonin to discriminate infection from non-infective inflammation using two pleural disease settings.

Authors:  Fiona J McCann; Stephen J Chapman; Wai Cho Yu; Nick A Maskell; Robert J O Davies; Y C Gary Lee
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

10.  Parapneumonic empyema deaths during past century, Utah.

Authors:  Jeffrey M Bender; Krow Ampofo; Xiaoming Sheng; Andrew T Pavia; Lisa Cannon-Albright; Carrie L Byington
Journal:  Emerg Infect Dis       Date:  2009-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.